1. Amitai, G., Kloog, Y., Balderman, D., and Sokolovsky, M., 1980, The interaction of bis-pyridimium oximes with mouse brain muscarinic receptor, Biochem. Pharmacol 29: 483–488.
2. Amitai, G., Rabinovitz, I., Chen, R., Cohen, G., Zomber, G., Adani, R., Manistersky, B., Leader, H., and Raveh, L., 1993, Antidotal efficacy of bisquaternary oximes against soman and tabun poisoning in various species, in 1993 Medical Defense Bioscience Review, Proceedings, Vol. 2, Baltimore Convention Center, Baltimore, Maryland, May 10–13, U.S. Army Medical Research and Materiel Command, Fort Detrick, Frederick, Maryland.
3. Baggot, J.D., Buckpitt, A., Johnson, D., Brennan, P., Cone, N., and Goldman, M., 1990, Bioavailability, disposition and pharmacokinetic study of WR249, 655 (HI-6) in Beagle Dogs, U.S. Army Medical Research and Materiel Command, Washington, DC, Contract No. DAMD17-86-C-6177, Task Order UCD#9, Draft Study Report.
4. Boeke, A.W., 1978, The stability of pralidoxime salts in solution-a review, Pharm. Weekb. 113: 713–718.
5. Boškoviċ, B., 1981, The treatment of soman poisoning and its perspectives, Fundam. Appl. Toxicol. 1: 203–213.